サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426392

パニック障害の世界市場レポート 2024年

Panic Disorders Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
パニック障害の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

パニック障害の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.1%の年間複合成長率（CAGR）で130億7,000万米ドルに成長すると予想されます。予測期間の成長は、薬物治療の出現、遠隔精神医学サービスの拡大、併存疾患への焦点、世界のメンタルヘルスへの取り組み、治療における薬理ゲノミクスの統合、と公教育プログラムに起因すると考えられます。予測期間の主要動向には、デジタルメンタルヘルス介入、パニック障害治療のための遠隔医療の利用、医薬品の革新、神経生物学的調査の進歩、遠隔モニタリングとウェアラブル技術の採用が含まれます。

精神科患者の急増により、予見可能な将来、パニック障害市場の拡大が促進される展望です。精神疾患患者は、認知機能、感情機能、社会機能のさまざまな側面を混乱させる精神的健康状態の影響を受けており、突然の激しい不安症状を特徴とするパニック障害になりやすいです。精神疾患に対処する個人の治療には、パニック発作の症状を緩和し、全体的な幸福度を高め、効果的な対処メカニズムを促進するために、治療、投薬、ライフスタイルの修正を組み合わせた多面的なアプローチが必要となることがよくあります。たとえば、Mental Health Americaによる2022年のアメリカのメンタルヘルス状況報告書では、精神疾患患者の増加が指摘されており、2022年の米国総人口の19.00%を占める4,713万2,000人に比べて、4,956万4,000人に達し、2022年の米国総人口の19.86%を占めています。したがって、精神科患者数の増加がパニック障害市場の成長を促進すると予想されます。

遠隔医療サービスの導入の増加により、今後数年間でパニック障害市場の拡大が促進されると予想されます。テレヘルスは、ビデオ会議、電話、安全なメッセージングなどの電子通信技術を活用して、遠隔の医療サービスや相談を提供します。 パニック障害の領域では、遠隔医療により心理療法とカウンセリングサービスが可能になり、セラピストが安全なビデオ会議ツールを通じて個人またはグループの療法セッションやサポートグループを実施するためのプラットフォームが提供されます。その一例として、FAIR Health Inc.のレポートでは、遠隔医療の利用が国全体で7.3%増加し、2022年 12月の医療請求明細の5.5%から2023年 1月の5.9%に増加していることが強調されています。この遠隔医療プラットフォームへの依存の高まりは、 パニック障害市場の成長を促しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のパニック障害市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のパニック障害の市場規模実績と成長率、2018～2023年
  • 世界のパニック障害市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界のパニック障害市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 広場恐怖症
  • 社会不安障害（SAD）
  • 強迫性障害（OCD）
  • 双極性障害
  • 心的外傷後ストレス障害（PTSD）
  • 特定の恐怖症
  • 全般性不安障害（GAD）
  • 大鬱病性障害
  • 世界のパニック障害市場、治療別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 薬物治療
  • ベータブロッカー
  • セロトニンとノルアドレナリン再取り込み阻害剤（SNRI）
  • ベンゾジアゼピン系
  • 抗てんかん
  • その他
  • 世界のパニック障害市場、投与経路別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界のパニック障害市場、最終用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局ストア

第7章 地域と国の分析

  • 世界のパニック障害市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界のパニック障害市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • パニック障害市場の競合情勢
  • パニック障害市場の企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Sanofi SA
    • Bristol-Myers Squibb Company
    • AstraZeneca plc
    • Abbott Laboratories

第31章 その他の大手と革新的な企業

  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH.
  • Baxter Inc
  • Teva Pharmaceutical Industries Ltd
  • Mylan NV
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc.
  • H. Lundbeck A/S
  • Shionogi &Co Ltd.
  • Recordati SpA
  • Neurocrine Biosciences Inc
  • Neuraxpharm
  • Actavis Plc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13404

Panic disorder is a specific type of anxiety condition characterized by unexpected and recurring episodes of intense anxiety accompanied by physical symptoms such as shortness of breath, chest pain, heart palpitations, nausea, and abdominal discomfort. Treatment for panic disorder typically involves a combination of medication and psychotherapy.

The main subtypes of panic disorders include agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCS), bipolar disorder, post-traumatic stress disorder (PTSD), and major depressive disorder. Agoraphobia involves the intentional avoidance of places or situations that may trigger panic symptoms, leading to feelings of confinement, helplessness, or social discomfort. Various treatment options include medication, beta-blockers, serotonin and norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, anti-epilepsy medications, and others, which can be administered orally, through injections, and other methods. These treatments are available through hospital pharmacies, retail pharmacies, and online pharmacy stores.

The panic disorders market research report is one of a series of new reports from The Business Research Company that provides panic disorders market statistics, including panic disorders industry global market size, regional shares, competitors with a panic disorders market share, detailed panic disorders market segments, market trends and opportunities, and any further data you may need to thrive in the panic disorders industry. This panic disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The panic disorders market size has grown strongly in recent years. It will grow from $10.19 billion in 2023 to $10.73 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historical period can be attributed to the use of antidepressant medications, heightened awareness of mental health issues, rising stress levels, improved access to mental health services, and advancements in diagnostic criteria.

The panic disorders market size is expected to see strong growth in the next few years. It will grow to $13.07 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the emergence of pharmacological treatments, the expansion of telepsychiatry services, a focus on comorbidities, global mental health initiatives, the integration of pharmacogenomics in treatment, and public education programs. Major trends in the forecast period include digital mental health interventions, the use of telemedicine for panic disorder treatment, innovations in medications, advancements in neurobiological research, and the adoption of remote monitoring and wearable technology.

An upsurge in the population of psychiatric patients is poised to propel the expansion of the panic disorder market in the foreseeable future. Psychiatric patients, affected by mental health conditions that disrupt various aspects of their cognitive, emotional, and social functioning, are susceptible to panic disorder, characterized by sudden and intense episodes of anxiety. Treatment for individuals dealing with psychiatric conditions often involves a multifaceted approach combining therapy, medication, and lifestyle modifications to alleviate panic attack symptoms, enhance overall well-being, and foster effective coping mechanisms. For instance, the State of Mental Health in America 2022 report by Mental Health America noted an increase in psychiatric patients, reaching 49,564,000 individuals, constituting 19.86% of the total US population in 2022, compared to 47,132,000 individuals, comprising 19.00% of the total US population in 2021. Hence, the rise in psychiatric patient numbers is set to drive the growth of the panic disorder market.

The growing adoption of telehealth services is anticipated to propel the expansion of the panic disorders market in the coming years. Telehealth leverages electronic communication technologies such as video conferencing, phone calls, and secure messaging to deliver remote healthcare services and consultations. In the realm of panic disorders, telehealth enables psychotherapy and counseling services, offering platforms for therapists to conduct individual or group therapy sessions, as well as support groups, through secure video conferencing tools. As an illustration, a report by FAIR Health Inc. highlighted a 7.3% national increase in telehealth usage, from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. This growing reliance on telehealth platforms signifies a driving force behind the growth of the panic disorders market.

The high costs associated with panic disorder treatment and the limitations in insurance coverage can pose significant challenges, potentially restricting the market's growth during the forecast period. The expenses linked to managing panic disorder are often substantial due to the necessity for prolonged therapy, medications, and specialized care. Moreover, the constrained insurance coverage for mental health services frequently results in patients having to bear a significant portion of the treatment expenses. For instance, a report from Addiction Rehab Toronto in May 2021 indicated that anxiety treatment for a two-week session cost around $8,000, with a potential increase of $2,000 for treating PTSD and panic attacks. Cognitive-behavioral therapy (CBT) sessions could cost up to $100 per hour. Hence, the high treatment costs and limited insurance coverage serve as hindrances to the expansion of the panic disorder market.

Key companies engaged in the panic disorder market are concentrating on the development of advanced medications, notably extended-release capsules, to fortify their foothold in the market. Extended-release capsules are medications designed to gradually release the active ingredients over an extended period, typically 12 or 24 hours, suitable for managing conditions requiring prolonged medication. As an example, in May 2023, Granules India Ltd., an Indian pharmaceutical company, obtained abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules. These capsules have demonstrated bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed to manage various conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They operate by increasing serotonin and norepinephrine levels in the brain, usually starting at a dosage of 75 mg per day and adjusted as required under a doctor's supervision.

In February 2023, Vistagen Therapeutics Inc., a clinical-stage biopharmaceutical company based in the United States, successfully acquired Pherin Pharmaceuticals Inc. for an undisclosed sum. This strategic acquisition positions Vistagen to advance and bring to market innovative treatments designed for individuals dealing with depression and anxiety disorders. The collaboration is anticipated to enhance the commercial prospects of each drug candidate, strengthening Vistagen's portfolio in addressing mental health challenges. Pherin Pharmaceuticals Inc., the acquired company, specializes in drug development focused on panic disorders.

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd, VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

North America was the largest region in the panic disorders market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the panic disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The panic disorder market consists of revenue earned by entities by providing services such as physical tests, cognitive behavioral therapy (CBT), and psychological evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic disorder market includes sales of tablets and injectables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panic Disorders Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panic disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panic disorders? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panic disorders market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Agoraphobia; Social Anxiety Disorder (SAD); Obsessive-Compulsive Disorder (OCD); Bipolar Disorder; Post-Traumatic Stress Disorder (PTSD); Major Depressive Disorder
  • 2) By Treatment: Medication; Beta Blockers; Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs); Benzodiazepines; Anti-Epilepsy; Other Treatments
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
  • 4) By End Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Sanofi S.A; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Panic Disorders Market Characteristics

3. Panic Disorders Market Trends And Strategies

4. Panic Disorders Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Panic Disorders Market Size and Growth

  • 5.1. Global Panic Disorders Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Panic Disorders Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Panic Disorders Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Panic Disorders Market Segmentation

  • 6.1. Global Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Agoraphobia
  • Social Anxiety Disorder (SAD)
  • Obsessive-Compulsive Disorder (OCD)
  • Bipolar Disorder
  • Post-Traumatic Stress Disorder (PTSD)
  • Specific Phobias
  • Generalized Anxiety Disorder (GAD)
  • Major Depressive Disorder
  • 6.2. Global Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medication
  • Beta Blockers
  • Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)
  • Benzodiazepines
  • Anti-Epilepsy
  • Other Treatments
  • 6.3. Global Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.4. Global Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retailer Pharmacies
  • Online Pharmacy Stores

7. Panic Disorders Market Regional And Country Analysis

  • 7.1. Global Panic Disorders Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Panic Disorders Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Panic Disorders Market

  • 8.1. Asia-Pacific Panic Disorders Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Panic Disorders Market

  • 9.1. China Panic Disorders Market Overview
  • 9.2. China Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Panic Disorders Market

  • 10.1. India Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Panic Disorders Market

  • 11.1. Japan Panic Disorders Market Overview
  • 11.2. Japan Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Panic Disorders Market

  • 12.1. Australia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Panic Disorders Market

  • 13.1. Indonesia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Panic Disorders Market

  • 14.1. South Korea Panic Disorders Market Overview
  • 14.2. South Korea Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Panic Disorders Market

  • 15.1. Western Europe Panic Disorders Market Overview
  • 15.2. Western Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Panic Disorders Market

  • 16.1. UK Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Panic Disorders Market

  • 17.1. Germany Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Panic Disorders Market

  • 18.5. France Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Panic Disorders Market

  • 19.9. Italy Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Panic Disorders Market

  • 20.13. Spain Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Panic Disorders Market

  • 21.1. Eastern Europe Panic Disorders Market Overview
  • 21.2. Eastern Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Panic Disorders Market

  • 22.1. Russia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Panic Disorders Market

  • 23.1. North America Panic Disorders Market Overview
  • 23.2. North America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Panic Disorders Market

  • 24.1. USA Panic Disorders Market Overview
  • 24.2. USA Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Panic Disorders Market

  • 25.1. Canada Panic Disorders Market Overview
  • 25.2. Canada Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Panic Disorders Market

  • 26.1. South America Panic Disorders Market Overview
  • 26.2. South America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Panic Disorders Market

  • 27.1. Brazil Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Panic Disorders Market

  • 28.1. Middle East Panic Disorders Market Overview
  • 28.2. Middle East Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Panic Disorders Market

  • 29.1. Africa Panic Disorders Market Overview
  • 29.2. Africa Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Panic Disorders Market Competitive Landscape And Company Profiles

  • 30.1. Panic Disorders Market Competitive Landscape
  • 30.2. Panic Disorders Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sanofi S.A
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bristol-Myers Squibb Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AstraZeneca plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Panic Disorders Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline plc
  • 31.2. Eli Lilly and Company
  • 31.3. Boehringer Ingelheim International GmbH.
  • 31.4. Baxter Inc
  • 31.5. Teva Pharmaceutical Industries Ltd
  • 31.6. Mylan N.V.
  • 31.7. Pfizer Inc.
  • 31.8. Sun Pharmaceutical Industries Ltd
  • 31.9. Bausch Health Companies Inc.
  • 31.10. H. Lundbeck A/S
  • 31.11. Shionogi & Co Ltd.
  • 31.12. Recordati S.p.A
  • 31.13. Neurocrine Biosciences Inc
  • 31.14. Neuraxpharm
  • 31.15. Actavis Plc.

32. Global Panic Disorders Market Competitive Benchmarking

33. Global Panic Disorders Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Panic Disorders Market

35. Panic Disorders Market Future Outlook and Potential Analysis

  • 35.1 Panic Disorders Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Panic Disorders Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Panic Disorders Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer